Effect of pioglitazone on carotid intima-media thickness and arterial stiffness in type 2 diabetic nephropathy patients

Metabolism: Clinical and Experimental

Volumn 53, Issue 10, 2004, Pages 1382-1386

  Nakamura, Tsukasa ^a,b   Matsuda, Takaharu ^a,b   Kawagoe, Yasuhiro ^a,b   Ogawa, Hiroshi ^a,b   Takahashi, Yutaka ^a,b   Sekizuka, Keiko ^a,b   Koide, Hikaru ^a,b  

^a Shinmatsudo Central General Hospital   (Japan)

^b KOTO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GLIBENCLAMIDE; PIOGLITAZONE; VOGLIBOSE;

ADULT; AGED; ARTERY COMPLIANCE; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; CAROTID ARTERY; CAROTID ARTERY PULSE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TREATMENT OUTCOME; URINARY EXCRETION;

ALBUMINURIA; BLOOD PRESSURE; BLOOD UREA NITROGEN; CAROTID ARTERIES; CREATININE; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; ENZYME INHIBITORS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INOSITOL; MALE; MIDDLE AGED; PROTEIN PRECURSORS; SULFONYLUREA COMPOUNDS; THIAZOLIDINEDIONES;

EID: 4544348898     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.05.013     Document Type: Article

References (35)

1. Ginsberg H., Plutzky J., Sobel B.E. A review of metabolic and cardiovascular effects of oral antidiabetic agents Beyond glucose-level lowering. J Cardiovasc Risk. 6:1999;337-346
2. Martens F.M., Visseren F.L., Lemay J., et al. Metabolic and additional vascular effects of thiazolidinediones. Drugs. 62:2002;1463-1480
3. Yoshimoto T., Naruse M., Shizime H., et al. Vasculo-protective effects of insulin sensitizing agent pioglitazone in neointimal thickening and hypertensive vascular hypertrophy. Atherosclerosis. 145:1999;333-340
4. Nakamura T., Ushiyama C., Shimada N., et al. Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients. J Diabetes Complications. 14:2000;250-254
5. Yamashita H., Nagai Y., Takamura T., et al. Thiazolidinedione derivatives ameliorate albuminuria in streptozotocin-induced diabetic spontaneous hypertensive rat. Metabolism. 51:2002;403-408
6. Bakris G., Viberti G., Weston W.M., et al. Rosiglitazone reduces urinary albumin excretion in type 2 diabetes. J Hum Hypertens. 17:2003;7-12
7. Raso F.M., van Popele N.M., Schalekamp M.A., et al. Intima-media thickness of the common carotid arteries is related to coronary atherosclerosis and left ventricular hypertrophy in older adults. Angiology. 53:2002;569-574
8. Lehmann E.D., Riley W.A., Clarkson P., et al. Noninvasive assessment of cardiovascular disease in diabetes mellitus. Lancet. 350:(suppl 1):1997;14-19
9. Ichihara A., Hayashi M., Ryuzaki M., et al. Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus. Nephrol Dial Transplant. 17:2002;1513-1517
10. Sidhu J.S., Kaposzta Z., Markus H.S., et al. Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus. Arterioscler Thromb Vasc Biol. 24:2004;930-934
11. Marx N., Froehlich J., Siam L., et al. Antidiabetic PPAR-γ- activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 23:2003;283-288
12. Stakos D.A., Schuster D.P., Sparks E.A., et al. Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance Double blind, prospective randomized study. J Cardiol. 41:2003;183-190
13. Koshiyama H., Shimono D., Kuwamura N., et al. Rapid communication Inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes. J Clin Endocrinol Metab. 86:2001;3452-3456
14. Tosi F., Muggeo M., Brun E., et al. Combination treatment with metformin and glibenclamide versus single drug therapies in type 2 diabetes mellitus A randomized, double-blind, comparative study. Metabolism. 52:2003;862-867
15. Alvarsson M., Sundkvist G., Lager L., et al. Beneficial effects of insulin versus sulfonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients. Diabetes Care. 26:2003;2231-2237
16. Takami K., Takeda N., Nakashima K., et al. Effects of dietary treatment alone or diet with voglibose or glyburide on abdominal adipose tissue and metabolic abnormalities in patients with newly diagnosed type 2 diabetes. Diabetes Care. 25:2002;658-662
17. Maeda N., Sawayama Y., Tatsukawa M., et al. Chlamydia pneumoniae seropositivity and early carotid atherosclerosis in a suburban Japanese population. Atherosclerosis. 164:2002;313-319
18. Roberts A.W., Thomas A., Rees A., et al. Peroxisome proliferators- activated receptor-γ agonists in atherosclerosis Current evidence and future directions. Curr Opin Lipidol. 14:2003;567-573
19. Tham D.M., Wang Y.X., Rutledge J.C. Modulation of vascular inflammation by PPARs. Drug News Perspect. 16:2003;109-116
20. Nakamura T., Ushiyama C., Osada S., et al. Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria. Metabolism. 50:2001;1193-1196
21. Shoji T., Emoto M., Tabata T., et al. Advanced atherosclerosis in predialysis patients with chronic renal failure. Kidney Int. 61:2002;2187-2192
22. Ravikumar R., Deepa R., Shanthirani C., et al. Comparison of carotid intima- media thickness, arterial stiffness, and brachial artery flow mediated dilatation in diabetic and nondiabetic subjects. Am J Cardiol. 90:2002;702-707
23. Yamashita A., Tomiyama H., Takeda K., et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res. 25:2002;359-364
24. Komai N., Ohishi M., Morishita R., et al. Serum hepatocyte growth factor concentration is correlated with the forearm vasodilator response in hypertensive patients. Am J Hypertens. 15:2002;499-506
25. Mahmud A., Feely J. Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition. Am J Hypertens. 15:2002;321-325
26. Ludwig M., Stapff M., Ribeiro A., et al. Comparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension Results of a 2-year, double-blind, randomized, controlled study. Clin Ther. 24:2002;1175-1193
27. Taylor A.J., Kent S.M., Flaherty P.J., et al. ARBITER: Arterial biology for the investigation of the treatment. Effects of reducing cholesterol: A randomized trial comparing the effects of atrovastatin and pravastatin on carotid intima medial thickness. Circulation. 106:2002;2055-2060
28. Youssef F., Seifalian A.M., Jagroop I.A., et al. The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT). Eur J Vasc Endovasc Surg. 23:2002;358-364
29. Nolting P.R., de Groot E., Zwinderman A.H., et al. Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia Treatment with simvastatin. Arch Intern Med. 163:2003;1837-1841
30. Parving H.H. Renoprotection in diabetes Genetic and non-genetic risk factors and treatment. Diabetologia. 41:1998;745-759
31. Mogensen C.E. Microalbuminuria, blood pressure and diabetic renal diseases Origin and development of ideas. Diabetologia. 42:1999;263-285
32. Agewall S., Fagerberg B., Ljungman S., et al. Urinary albumin excretion is associated with the intima-media thickness of the carotid artery in hypertensive males with non-insulin-dependent diabetes mellitus. J Hypertens. 13:1995;463-469
33. Pedrinelli R., Dell'Omo G., Penno G., et al. Dissociation between microalbuminuria and common carotid thickness in essential hypertensive men. J Hum Hypertens. 14:2000;831-835
34. Agewall S., Fagerberg B., Attvall S., et al. Microalbuminuria, insulin sensitivity and hemostatic factors in treated hypertensive men with normal fasting blood glucose. J Intern Med. 237:1995;195-203
35. Mykkanen L., Zaccaro D.J., Wagenknecht L.E., et al. Microalbuminuria is associated with insulin resistance in nondiabetic subjects The Insulin Resistance Atherosclerosis Study. Diabetes. 47:1998;793-800